secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0000078003-22-000066
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pfizer shareholders elect all 12 director nominees, defeat all four shareholder proposals at 2022 annual meeting
--------------------------------------------------------------------------------

- All 12 Board nominees elected, including CEO Albert Bourla and independent directors.
- Ratification of KPMG as independent auditor for FY2022 approved with 4.44B votes for.
- Advisory say-on-pay resolution for named executives approved with 3.51B votes for.
- Four shareholder proposals (proxy access, political spending, IP transfer, anticompetitive risks) all defeated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000007800322000066/0000078003-22-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000007800322000066/pfe-20220428.htm
  HTML page:      https://secwatch.observer/filing/0000078003-22-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer